ABBOTINDIA · Healthcare
Abbott India Ltd. reported revenue of ₹1,738 cr for April to June 2025, +11.6% on the year and +8.3% on the quarter. It is the highest quarterly revenue in the last 9 quarters on record. Over the last four quarters revenue comes to ₹6,590 cr, +11.2% on the four before.
Operating profit (EBITDA) was ₹446 cr, a margin of 25.7%, +57 bps on the year and −107 bps on the quarter. Over the last 8 quarters the margin has ranged from 22.9% to 27.0%, averaging 25.9%. Operating costs grew +10.7% against revenue growth of +11.6%, so more of each rupee of sales reached operating profit.
Net profit was ₹366 cr, +11.6% on the year and −0.3% on the quarter, with earnings per share of ₹172.18. Profit before other income, one-offs and tax grew 13.5%, so the profit growth came from the business itself. The tax rate of 26% is in line with its recent average. Profit over the last four quarters totals ₹1,453 cr, +17.3% on the four before.
On earnings per share of ₹683.45 over the last four quarters, the stock at ₹26,185.00 trades at 38.3 times trailing earnings.
Written from the quarterly statements. The filing read adds the balance sheet and cash flow, the auditor's review, segment results, one-off items line by line and what management said on the call.
No check fired. That is a statement about the checks below, not a verdict on the company.
Could not run on this quarter: Exceptional items that recur, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).
Net profit a year ago, each driver's change, and net profit now. Blue added profit, red took it away.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,494 cr | ₹1,437 cr | ₹1,439 cr | ₹1,558 cr | ₹1,633 cr | ₹1,614 cr | ₹1,605 cr | ₹1,738 cr | ₹1,757 cr | ₹1,724 cr | ₹1,710 cr | ₹1,814 cr |
| YoY | — | — | — | +5% | +9% | +12% | +12% | +12% | +8% | +7% | +7% | +4% |
| EBITDA margin | 25.5% | 27.0% | 22.9% | 25.1% | 26.9% | 27.0% | 26.7% | 25.7% | 28.6% | 26.9% | 28.1% | 28.8% |
| Other income, % of PBT | 13% | 13% | 21% | 15% | 13% | 15% | 16% | 15% | 13% | 14% | 14% | 13% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 25% | 26% | 26% | 25% | 25% | 26% | 24% | 26% | 24% | 26% | 26% | 25% |
| Net profit | ₹313 cr | ₹311 cr | ₹287 cr | ₹328 cr | ₹359 cr | ₹361 cr | ₹367 cr | ₹366 cr | ₹415 cr | ₹376 cr | ₹395 cr | ₹429 cr |
| YoY | — | — | — | +13% | +15% | +16% | +28% | +12% | +16% | +4% | +8% | +17% |
| Core profit YoY | — | — | — | +11% | +17% | +14% | +32% | +14% | +14% | +6% | +12% | +18% |
| EPS | ₹147.27 | ₹146.35 | ₹135.09 | ₹154.36 | ₹168.76 | ₹169.78 | ₹172.73 | ₹172.18 | ₹195.43 | ₹176.93 | ₹185.86 | ₹201.66 |
| Flags | · | · | · | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Abbott India Ltd. reported revenue of ₹1,738 cr (+11.6% on the year) and net profit of ₹366 cr (+11.6% on the year) for April to June 2025.
Profit before other income, exceptional items and tax moved +13.5% on the year, against +11.6% for reported profit.
None of the 7 checks that could run raised a question.
No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.